Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Constellation has strong operating momentum, reflected in higher second-quarter adjusted operating EPS, raised 2026 guidance, new long-duration nuclear power agreements and regulatory progress toward restarting Crane. A Hold recommendation balances those strengths against unfavorable nuclear outages, Calpine integration requirements.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets20 analysts · as of 18 Aug 2026
Low · most bearish analyst$290.00
Mean target$348.45
High · most bullish analyst$441.00
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$290.0020%

Additional nuclear outages or Calpine integration problems cause earnings to fall below guidance, while Crane slips beyond 2027 and anticipated value from new long-term contracts takes longer to emerge. Completion risk also remains around the DOJ-dependent Brazos Valley divestiture.

Base CaseCentral scenario
$348.4556%
Matches the consensus mean

Constellation delivers adjusted operating EPS within its $11.50-$12.50 2026 guidance range, progressively integrates Calpine, maintains broadly stable fleet performance and advances Crane toward a 2027 restart.

Bull CaseUpside scenario
$441.0024%

Constellation exceeds its raised 2026 earnings range, integrates Calpine without material disruption, converts its expanded generation portfolio into sustained commercial gains, and restarts Crane during 2027. The additional 920 MW of long-term nuclear agreements improves earnings visibility beyond the current guidance period.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Second-quarter 2026 adjusted operating EPS rose to $2.55 from $1.91 a year earlier, and full-year guidance was raised to $11.50-$12.50 per share.
  • Constellation signed another 920 MW of 15-to-20-year nuclear power agreements and secured important FERC and NRC milestones supporting Crane's planned 2027 restart.
Sign in / Sign up to read more
Key Investment Risks
  • Unfavorable nuclear outages partially offset the benefits from Calpine and favorable market and portfolio conditions during the second quarter.
  • The investment case depends on successful Calpine integration, timely Crane execution and completion of the Brazos Valley divestiture, which remains subject to DOJ approval and other closing conditions.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.